The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Mechanisms for oncogenic activation of the epidermal growth factor receptor
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
Engelman, J. A., Zejnullahu, K., Mitsudomi, T., Song, Y., Hyland, C., Park, J. O., Lindeman, N., Gale, C.-M., Zhao, X., Christensen, J., et al. (2007) · Science · doi:10.1126/science.1141478 · Cited by 4,496
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774
Nicholson, R. I., Gee, J. M. W., & Harper, M. E. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00231-3 · Cited by 2,143
Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways
Sordella, R., Bell, D. W., Haber, D. A., & Settleman, J. (2004) · Science · doi:10.1126/science.1101637 · Cited by 1,606
Prenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., & Ullrich, A. (1999) · Nature · doi:10.1038/47260 · Cited by 1,504
Hirsch, F. R., Varella-Garcia, M., Bunn, P. A., Di Maria, M. V., Veve, R., Bremnes, R. M., Barón, A. E., Zeng, C., & Franklin, W. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.069 · Cited by 1,477
Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors
Daub, H., Ulrich Weiss, F., Wallasch, C., & Ullrich, A. (1996) · Nature · doi:10.1038/379557a0 · Cited by 1,476
Integrin signalling during tumour progression
Guo, W., & Giancotti, F. G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1490 · Cited by 1,471
Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains
Ogiso, H., Ishitani, R., Nureki, O., Fukai, S., Yamanaka, M., Kim, J.-H., Saito, K., Sakamoto, A., Inoue, M., Shirouzu, M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00963-7 · Cited by 1,227
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
Li, S., Schmitz, K. R., Jeffrey, P. D., Wiltzius, J. J. W., Kussie, P., & Ferguson, K. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.003 · Cited by 1,118
The Tyrosine Kinase Negative Regulator c-Cbl as a RING-Type, E2-Dependent Ubiquitin-Protein Ligase
Joazeiro, C. A. P., Wing, S. S., Huang, H.-K., Leverson, J. D., Hunter, T., & Liu, Y.-C. (1999) · Science · doi:10.1126/science.286.5438.309 · Cited by 1,034
Role of Tyrosine Kinase Inhibitors in Cancer Therapy
Arora, A., & Scholar, E. M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084145 · Cited by 1,014
Levkowitz, G., Waterman, H., Ettenberg, S. A., Katz, M., Tsygankov, A. Y., Alroy, I., Lavi, S., Iwai, K., Reiss, Y., Ciechanover, A., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80231-2 · Cited by 1,001
Ligand-Induced, Receptor-Mediated Dimerization and Activation of EGF Receptor
Schlessinger, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00966-2 · Cited by 993
Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation.
Pagès, G., Lenormand, P., L'Allemain, G., Chambard, J. C., Meloche, S., & Pouysségur, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8319 · Cited by 984
Mitsudomi, T., Kosaka, T., Endoh, H., Horio, Y., Hida, T., Mori, S., Hatooka, S., Shinoda, M., Takahashi, T., & Yatabe, Y. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.992 · Cited by 948
Moroni, M., Veronese, S., Benvenuti, S., Marrapese, G., Sartore-Bianchi, A., Di Nicolantonio, F., Gambacorta, M., Siena, S., & Bardelli, A. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70102-9 · Cited by 941
Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth
Agus, D. B., Akita, R. W., Fox, W. D., Lewis, G. D., Higgins, B., Pisacane, P. I., Lofgren, J. A., Tindell, C., Evans, D. P., Maiese, K., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00097-1 · Cited by 873
c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor
Levkowitz, G., Waterman, H., Zamir, E., Kam, Z., Oved, S., Langdon, W. Y., Beguinot, L., Geiger, B., & Yarden, Y. (1998) · Genes & Development · doi:10.1101/gad.12.23.3663 · Cited by 865
Structural alterations of the epidermal growth factor receptor gene in human gliomas.
Wong, A. J., Ruppert, J. M., Bigner, S. H., Grzeschik, C. H., Humphrey, P. A., Bigner, D. S., & Vogelstein, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2965 · Cited by 853
Wong, A. J., Bigner, S. H., Bigner, D. D., Kinzler, K. W., Hamilton, S. R., & Vogelstein, B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6899 · Cited by 849
Goldstein, N. I., Prewett, M. C., Zuklys, K., Rockwell, P., & Mendelsohn, J. M. (1995) · PubMed · Cited by 785
Garrett, T. P. J., McKern, N. M., Lou, M., Elleman, T. C., Adams, T. E., Lovrecz, G. O., Zhu, H.-J., Walker, F., Frenkel, M. J., Hoyne, P. A., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00940-6 · Cited by 783
Sandgren, E. P., Luetteke, N. C., Palmiter, R. D., Brinster, R. L., & Lee, D. C. (1990) · Cell · doi:10.1016/0092-8674(90)90075-p · Cited by 752
Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.
Frederick, L. A., Wang, X. Y., Eley, G. D., & James, C. D. (2000) · PubMed · Cited by 740
Asakura, M., Kitakaze, M., Takashima, S., Liao, Y., Ishikura, F., Yoshinaka, T., Ohmoto, H., Node, K., Yoshino, K., Ishiguro, H., et al. (2002) · Nature Medicine · doi:10.1038/nm0102-35 · Cited by 724
Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation
Haglund, K., Sigismund, S., Polo, S., Szymkiewicz, I., Di Fiore, P. P., & Dikic, I. (2003) · Nature Cell Biology · doi:10.1038/ncb983 · Cited by 715
Prenzel, N., Fischer, O. M., Streit, S., Hart, S., & Ullrich, A. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080011 · Cited by 673
Signal characteristics of G protein-transactivated EGF receptor
Daub, H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.7032 · Cited by 658
Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin).
Sliwkowski, M. X., Ja, L., Gd, L., Te, H., FENDLY, B. M., & Fox, J. A. (1999) · PubMed · Cited by 653
Biscardi, J. S., Maa, M.-C., Tice, D. A., Cox, M. E., Leu, T.-H., & Parsons, S. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8335 · Cited by 649
Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors.
Moscatello, D. K., Holgado-Madruga, M., Godwin, A. K., Ramirez, G., Gunn, G. R., Zoltick, P. W., Biegel, J. A., Hayes, R. L., & Wong, A. J. (1995) · PubMed · Cited by 637
Garrett, T. P. J., McKern, N. M., Lou, M., Elleman, T. C., Adams, T. E., Lovrecz, G. O., Kofler, M., Jorissen, R. N., Nice, E. C., Burgess, A. W., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00048-0 · Cited by 613
The ErbB receptors and their role in cancer progression
Holbro, T. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00099-x · Cited by 608
Moro, L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6622 · Cited by 584
Hirsch, F. R., Varella-Garcia, M., McCoy, J., West, H., Xavier, A. C., Gumerlock, P., Bunn, P. A., Franklin, W. A., Crowley, J., & Gandara, D. R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.2823 · Cited by 574
The EGFR as a target for anticancer therapy—focus on cetuximab
Baselga, J. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00233-7 · Cited by 563
Huang, S.-F., Liu, H.-P., Li, L.-H., Ku, Y.-C., Fu, Y.-N., Tsai, H.-Y., Chen, Y.-T., Lin, Y.-F., Chang, W.-C., Kuo, H.-P., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1245 · Cited by 548
Futter, C. E., Pearse, A., Hewlett, L. J., & Hopkins, C. R. (1996) · The Journal of cell biology · doi:10.1083/jcb.132.6.1011 · Cited by 530
Luttrell, L. M., Hawes, B. E., van Biesen, T., Luttrell, D. K., Lansing, T. J., & Lefkowitz, R. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19443 · Cited by 525
Sok, J. C., Coppelli, F. M., Thomas, S. M., Lango, M. N., Xi, S., Hunt, J. L., Freilino, M. L., Graner, M. W., Wikstrand, C. J., Bigner, D. D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0913 · Cited by 492
Yamanaka, Y., Frieß, H., Kobrin, M. S., Büchler, M. W., Hg, B., & Korc, M. (1993) · PubMed · Cited by 461
Epidermal Growth Factor Receptor Dependence in Human Tumors: More Than Just Expression?
Arteaga, C. L. (2002) · The Oncologist · doi:10.1634/theoncologist.7-2004-31 · Cited by 455
Lenferink, A. E. G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3385 · Cited by 413
Ligand-Induced Transformation by a Noninternalizing Epidermal Growth Factor Receptor
Wells, A., Welsh, J. B., Lazar, C. S., Wiley, H. S., Gill, G. N., & Rosenfeld, M. G. (1990) · Science · doi:10.1126/science.2305263 · Cited by 411
Qian, X., Karpova, T., Sheppard, A. M., McNally, J., & Lowy, D. R. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600136 · Cited by 396
Agus, D. B., Gordon, M. S., Taylor, C., Natale, R. B., Karlan, B., Mendelson, D. S., Press, M. F., Allison, D. E., Sliwkowski, M. X., Lieberman, G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.184 · Cited by 390
Mamot, C., Drummond, D. C., Noble, C. O., Kallab, V., Guo, Z., Hong, K., Kirpotin, D. B., & Park, J. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1093 · Cited by 382
Moro, L., Dolce, L., Cabodi, S., Bergatto, E., Erba, E. B., Smeriglio, M., Turco, E., Retta, S. F., Giuffrida, M. G., Venturino, M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109101200 · Cited by 377
Zhou, B.-B. S., Peyton, M., He, B., Liu, C., Girard, L., Caudler, E., Lo, Y., Baribaud, F., Mikami, I., Reguart, N., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.024 · Cited by 374
Gebhardt, F., Zänker, K. S., & Brandt, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13176 · Cited by 372
Bhargava, R., Gerald, W. L., Li, A. R., Pan, Q., Lal, P., Ladanyi, M., & Chen, B. (2005) · Modern Pathology · doi:10.1038/modpathol.3800438 · Cited by 355
Prewett, M. C., Hooper, A. T., Bassi, R., Ellis, L. M., Waksal, H. W., & Hicklin, D. J. (2002) · PubMed · Cited by 352
TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells
Gschwind, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg231 · Cited by 342
Expression in rat fibroblasts of a human transforming growth factor-α cDNA results in transformation
Rosenthal, A., Lindquist, P. B., Bringman, T. S., Goeddel, D. V., & Derynck, R. (1986) · Cell · doi:10.1016/0092-8674(86)90747-6 · Cited by 335
Chen, P., Xie, H., Sekar, M. C., Gupta, K., & Wells, A. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.3.847 · Cited by 325
Worthylake, R., Opresko, L. K., & Wiley, H. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8865 · Cited by 325
EGF mutant receptor vIII as a molecular target in cancer therapy.
Kuan, C. T., Wikstrand, C. J., & Bigner, D. D. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080083 · Cited by 323
Xia, W., Lau, Y. K. J., Zhang, H. Z., Xiao, F. Y., Johnston, D. A., Liu, A. R., Li, L., Katz, R. L., & Hung, M. (1999) · PubMed · Cited by 295
(2004) · The Women's Oncology Review · doi:10.3109/14733400410001727592 · Cited by 288
Endocytosis of Receptor Tyrosine Kinases Is Driven by Monoubiquitylation, Not Polyubiquitylation
Mosesson, Y., Shtiegman, K., Katz, M., Zwang, Y., Vereb, G., Szollosi, J., & Yarden, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300096200 · Cited by 286
Waterman, H., Katz, M., Rubin, C., Shtiegman, K., Lavi, S., Elson, A., Jovin, T., & Yarden, Y. (2002) · The EMBO Journal · doi:10.1093/emboj/21.3.303 · Cited by 286
ErbB-1 and ErbB-2 Acquire Distinct Signaling Properties Dependent upon Their Dimerization Partner
Olayioye, M. A., Graus-Porta, D., Beerli, R. R., Rohrer, J., Gay, B., & Hynes, N. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5042 · Cited by 262
Sunada, H., Magun, B. E., Mendelsohn, J., & MacLeod, C. L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.3825 · Cited by 253
Ebner, R., & Derynck, R. (1991) · Cell Regulation · doi:10.1091/mbc.2.8.599 · Cited by 248
French, A. R., Tadaki, D. K., Niyogi, S. K., & Lauffenburger, D. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.9.4334 · Cited by 243
The type III epidermal growth factor receptor mutation
Pedersen, M. W., Meltorn, M., Damstrup, L., & Poulsen, H. S. (2001) · Annals of Oncology · doi:10.1023/a:1011177318162 · Cited by 241
Self-citationAmador, M. L., Oppenheimer, D., Perea, S., Maitra, A., Cusati, G., Iacobuzio-Donahue, C., Baker, S. D., Ashfaq, R., Takimoto, C., Forastiere, A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1036 · Cited by 241
Sampson, J. H., Akabani, G., Archer, G. E., Bigner, D. D., Berger, M. S., Friedman, A. H., Friedman, H. S., Herndon II, J. E., Kunwar, S., Marcus, S., et al. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1026290315809 · Cited by 239
Heimberger, A. B., Alexander, L. E. C., Archer, G. E., Hess, K. R., Wikstrand, C. J., Friedman, A. H., Friedman, H. S., Bigner, D. D., & Sampson, J. H. (2003) · PubMed · Cited by 234
Escape from Cbl-mediated downregulation
Peschard, P., & Park, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00136-3 · Cited by 233
Citri, A. (2002) · The EMBO Journal · doi:10.1093/emboj/21.10.2407 · Cited by 233
Epidermal growth factor receptor signaling
Bogdan, S., & Klämbt, C. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00167-1 · Cited by 226
Gschwind, A., Prenzel, N., & Ullrich, A. (2002) · PubMed · Cited by 220
EGF-Receptor Phosphorylation and Signaling Are Targeted by H 2 O 2 Redox Stress
Goldkorn, T., Balaban, N., Matsukuma, K., Chea, V., Gould, R., Last, J., Chan, C., & Chavez, C. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.19.5.3249 · Cited by 186
Growth factors: The epidermal growth factor receptor gene and its product
Hunter, T. (1984) · Nature · doi:10.1038/311414a0 · Cited by 184
CHU, C. T., EVERISS, K. D., WIKSTRAND, C. J., BATRA, S. K., KUNG, H.-J., & BIGNER, D. D. (1997) · Biochemical Journal · doi:10.1042/bj3240855 · Cited by 184
Bill, H. M., Knudsen, B., Moores, S. L., Muthuswamy, S. K., Rao, V. R., Brugge, J. S., & Miranti, C. K. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8586-8599.2004 · Cited by 183
Transcriptional Activation of the Human Epidermal Growth Factor Receptor Promoter by Human p53
Ludes-Meyers, J. H., Subler, M. A., Shivakumar, C. V., Munoz, R. M., Jiang, P., Bigger, J. E., Brown, D. R., Deb, S. P., & Deb, S. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6009 · Cited by 182
Wang, Z., Zhang, L., Yeung, T. K., & Chen, X. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.5.1621 · Cited by 181
EGFRvIII escapes down-regulation due to impaired internalization and sorting to lysosomes
Grandal, M. V., Zandi, R., Pedersen, M. W., Willumsen, B. M., van Deurs, B., & Poulsen, H. S. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm058 · Cited by 179
Self-citationLearn, C. A., Hartzell, T. L., Wikstrand, C. J., Archer, G. E., Rich, J. N., Friedman, A. H., Friedman, H. S., Bigner, D. D., & Sampson, J. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0521 · Cited by 173
ITOH, Y., JOH, T., Tanida, S., SASAKI, M., KATAOKA, H., Itoh, K., OSHIMA, T., Ogasawara, N., Togawa, S., & WADA, T. (2005) · Cytokine · doi:10.1016/j.cyto.2004.11.005 · Cited by 159
Constitutive Activation of c-Jun N-terminal Kinase by a Mutant Epidermal Growth Factor Receptor
Antonyak, M. A., Moscatello, D. K., & Wong, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2817 · Cited by 159
Fischer, O. M., Hart, S., Gschwind, A., Prenzel, N., & Ullrich, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5172-5183.2004 · Cited by 153
Johns, T. G., Adams, T. E., Cochran, J. R., Hall, N. E., Hoyne, P. A., Olsen, M. J., Kim, Y., Rothacker, J., Nice, E. C., Walker, F., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401218200 · Cited by 150
Kuwada, S. K., & Li, X. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.7.2485 · Cited by 148
Keely, S. J., Calandrella, S. O., & Barrett, K. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12619 · Cited by 145
The ErbB receptor tyrosine family as signal integrators.
Hynes, N. E., Horsch, K., Olayioye, M. A., & Badache, A. (2001) · Endocrine Related Cancer · doi:10.1677/erc.0.0080151 · Cited by 142
Cooking oil fumes and risk of lung cancer in women in rural Gansu, China
Metayer, C., Wang, Z., Kleinerman, R. A., Wang, L., Brenner, A. V., Cui, H., Cao, J.-S., & Lubin, J. H. (2002) · Lung Cancer · doi:10.1016/s0169-5002(01)00412-3 · Cited by 138
Shen, X., & Kramer, R. H. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63390-1 · Cited by 124
Riedel, H., Massoglia, S. L., Schlessinger, J., & Ullrich, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1477 · Cited by 124
Small molecules that reactivate mutant p53
Bykov, V. J. N., Selivanova, G., & Wiman, K. G. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00454-4 · Cited by 123
Haslekås, C., Breen, K., Pedersen, K. W., Johannessen, L. E., Stang, E., & Madshus, I. H. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-05-0456 · Cited by 117
Darmoul, D., Gratio, V., Devaud, H., Peiretti, F., & Laburthe, M. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.514.2.9 · Cited by 109
Ravid, T., Sweeney, C. A., Gee, P., Carraway, K. L., & Goldkorn, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204677200 · Cited by 106
Hart, S., Fischer, O. M., Prenzel, N., Zwick-Wallasch, E., Schneider, M., Hennighausen, L. G., & Ullrich, A. (2005) · Biological Chemistry · doi:10.1515/bc.2005.099 · Cited by 105
Dziadziuszko, R., Witta, S. E., Cappuzzo, F., Park, S.-J., Tanaka, K., Danenberg, P. V., Barón, A. E., Crinò, L., Franklin, W. A., Bunn, P. A., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0106 · Cited by 100
Humphrey, P. A., Gangarosa, L. M., Wong, A. J., Archer, G. E., Lund‐Johansen, M., Bjerkvig, R., Laerum, O.-D., Friedman, H. S., & Bigner, D. D. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91051-d · Cited by 99
Cohen, D., Simak, R., Fair, W. R., et al. (1994) · The Journal of Urology · doi:10.1016/s0022-5347(17)32335-2 · Cited by 93
Seth, D., Shaw, K., Jazayeri, J. A., & Leedman, P. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690407 · Cited by 86
Pedersen, M. W., Tkach, V., Pedersen, N. M., Berezin, V., & Poulsen, H. S. (2003) · International Journal of Cancer · doi:10.1002/ijc.11566 · Cited by 85
Self-citationThe role of ubiquitylation in signaling by growth factors: implications to cancer
Shtiegman, K., & Yarden, Y. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00097-4 · Cited by 85
Huang, R., Peng, A., Golard, A., Hossain, M. Z., Huang, R., Liu, Y., & Boynton, A. L. (2001) · Molecular Carcinogenesis · doi:10.1002/mc.1030 · Cited by 78
Frederick, L. A., Eley, G. D., Wang, X.-Y., & James, C. D. (2000) · Neuro-Oncology · doi:10.1093/neuonc/2.3.159 · Cited by 76
Mittendorf, E. A., Storrer, C. E., Shriver, C. D., Ponniah, S., & Peoples, G. E. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.03.069 · Cited by 72
Thomas, S. M., Grandis, J. R., Wentzel, A. L., Gooding, W. E., Lui, V. W. Y., & Siegfried, J. M. (2005) · Neoplasia · doi:10.1593/neo.04454 · Cited by 69
Pedersen, M. W., Pedersen, N. M., Damstrup, L., Villingshøj, M., Sønder, S. U., Rieneck, K., Bovin, L. F., Spang‐Thomsen, M., & Poulsen, H. S. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20554 · Cited by 62
Self-citationChrysogelos, S. A. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.24.5736 · Cited by 58
Johnston, D., Hall, H., DiLorenzo, T. P., & Steinberg, B. M. (1999) · PubMed · Cited by 57
Role of conformational alteration in the epidermal growth factor receptor (EGFR) function
Bishayee, S. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00425-1 · Cited by 56
Goldkorn, T., Ravid, T., & Khan, E. M. (2004) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.119 · Cited by 48
Sheikh, M. S., Carrier, F., Johnson, A. C., Ogdon, S. E., & Fornace, A. J. (1997) · Oncogene · doi:10.1038/sj.onc.1201264 · Cited by 47
Gulliford, T., Huang, G. C., Ouyang, X., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201595 · Cited by 43
de Wit, R., Langelaar‐Makkinje, M., Boonstra, J., Verkleij, A. J., & Post, J. A. (2000) · The FASEB Journal · doi:10.1096/fj.00-0454fje · Cited by 36
Hydrogen peroxide inhibits epidermal growth factor receptor internalization in human fibroblasts
de Wit, R., Capello, A., Boonstra, J., Verkleij, A. J., & Post, J. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00199-9 · Cited by 33
Ouyang, X., Gulliford, T., Huang, G.-C., & Epstein, R. J. (1999) · Journal of Cellular Physiology · Cited by 33
Garland, L. L., Hidalgo, M. M., Mendelson, D. S., Ryan, D. P., Arun, B. K., Lovalvo, J. L., Eiseman, I. A., Olson, S. C., Lenehan, P. F., & Eder, J. P. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2507 · Cited by 30
Fenstermaker, R. A., & Ciesielski, M. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203802 · Cited by 28
Cited by
EGFR Antagonists in Cancer Treatment
Ciardiello, F., & Tortora, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707704 · Cited by 2,058
Understanding and targeting resistance mechanisms in NSCLC
Rotow, J., & Bivona, T. G. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.84 · Cited by 972
Oncogenic EGFR Signaling Networks in Glioma
Huang, P. H., Xu, A. M., & White, F. M. (2009) · Science Signaling · doi:10.1126/scisignal.287re6 · Cited by 363
Han, J., Chu, J., Keung Chan, W., Zhang, J., Wang, Y., Cohen, J. B., Victor, A., Meisen, W. H., Kim, S.-H., Grandi, P., et al. (2015) · Scientific Reports · doi:10.1038/srep11483 · Cited by 340
Yang, J., Liao, D., Chen, C., Liu, Y., Chuang, T.-H., Xiang, R., Markowitz, D., Reisfeld, R. A., & Luo, Y. (2013) · Stem Cells · doi:10.1002/stem.1281 · Cited by 301
Metadata
- Authors
- Zandi, R., Larsen, A. B., Andersen, P., Stockhausen, M.-T., & Poulsen, H. S.
- Venue
- Cellular Signalling
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 19
- Issue
- 10
- Pages
- 2013-2023
- ISSN
- 0898-6568 (ISSN-L)
- OpenAlex
- W2015495715
- Cited by
- 303
- References
- 123
- FWCI
- 12.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.